Company: BLLN
Filing Date: 2025-12-10
Form Type: 10-Q
Source: 0001628280-25-056321
Chunk: 199

Company: BillionToOne, Inc.
Filing Date: 2025-12-10
Form: 10-Q
Item: Part I, Item 1
Chunk 199
---
 Accrued phlebotomy expense160 171 Accrued insurance expense75 159 Accrued rent122 160 Accrued clinical expenses242 98 Other366 271 Accrued expenses and other current liabilities$8,041 $3,882 

(5) Redeemable Convertible Preferred Stock

As of September 30, 2025 and December 31, 2024, redeemable convertible preferred stock consisted of the following (in thousands, except for share data):Shares AuthorizedShares IssuedandOutstandingNet Carrying ValueAggregateLiquidationPreferenceSeries A-11,349,6501,349,650$3,493 $540 Series A-21,137,2101,137,2102,943 910 Series A-3899,730899,7302,328 900 Series A-425,76125,76167 50 Series A-5114,613114,613297 100 Series A-65,805,8615,796,20114,999 15,000 Series B-15,182,2875,182,28754,889 55,000 Series B-22,566,9022,566,90227,243 16,025 Series C6,079,9195,628,825143,268 143,500 Series C-11,726,8231,726,82339,886 33,870 Series D4,656,2334,656,233129,996 156,563 Total29,544,98929,084,235$419,409 $422,458 

18

Table of ContentsBillionToOne, IncNotes to Unaudited Interim Financial Statements

(6) Commitments and Contingencies

Legal ProceedingsFrom time to time, the Company is party to certain claims in the ordinary course of business. The Company, in conjunction with its legal counsel, assesses the need to record a liability for litigation or contingencies. A liability is recorded when and if it is determined that such a liability for litigation or contingencies is both probable and the amount can be reasonably estimated. The Company believes that it is not presently a party to any litigation of which the outcome, if determined adversely, would individually or in the aggregate be expected to have a material and adverse effect on the business, operating results